Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL2993671

CN(C)CCCOc1ccnc2cc([N+](=O)[O-])ccc12.O=C(O)C(F)(F)F

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 3/20 0.42
ALDH1A1 P00352 4/20 0.40
MAPT P10636 4/20 0.40
GAA P10253 3/20 0.40
MAPK1 P28482 3/20 0.40
HTT P42858 3/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
KDM4E B2RXH2 1/20 0.39
APAF1 O14727 1/20 0.39
RAD52 P43351 1/20 0.39
CASP7 P55210 1/20 0.39
CASP6 P55212 1/20 0.39
CASP8 Q14790 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
RAB9A P51151 1/20 0.39
CHRNB2 P17787 1/20 0.38
CHRNA4 P43681 1/20 0.38
PDGFRA P16234 1/20 0.38
KDR P35968 1/20 0.38
MEN1 O00255 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2990677 0.91 MAPT (0.46) EGFRALDH1A1MAPTGAAMAPK1
SCHEMBL2993675 0.79 MAPT (0.41) ALDH1A1MAPTGAAMAPK1HTT
SCHEMBL15649292 0.73 CHRNB2 (0.50) ALDH1A1MAPTGAASMN1; SMN2KDM4E
SCHEMBL14923429 0.72 HTT (0.57) ALDH1A1MAPTGAAMAPK1HTT
SCHEMBL2990471 0.71 FERMT2 (0.65) HTTSMN1; SMN2KDM4ELMNA
Trifluoroacetic Acid SCHEMBL29197536 0.71 ALDH1A1 (0.37) ALDH1A1MAPTGAAHTTSMN1; SMN2
SCHEMBL3442297 0.71 S1PR4 (0.58) EGFRALDH1A1MAPTGAASMN1; SMN2
SCHEMBL11765505 0.69 KDM4E (0.57) ALDH1A1MAPTGAASMN1; SMN2KDM4E
SCHEMBL7519738 0.69 CHRNB2 (0.48) ALDH1A1MAPTGAASMN1; SMN2KDM4E
SCHEMBL7526257 0.69 CHRNB2 (0.45) ALDH1A1MAPTGAAHTTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100173332-A1 Method for the Fluorescent Detection of Nitroreductase Activity Using Nitro-Substituted Aromatic Compounds AUCKLAND UNISERVICES LIMITED 2010-07-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100173332-A1 Method for the Fluorescent Detection of Nitroreductase Activity Using Nitro-Substituted Aromatic Compounds BLVRB, POR, CBR3 EGFR 3511/4885ALDH1A1 119/4885MAPT 3792/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.